JWM
DGX icon

JPL Wealth Management’s Quest Diagnostics DGX Stock Holding History

JPL Wealth Management’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$77.8K Buy
+397
New +$77.1K 0.02% 183
2025
Q4 		– Sell
-387
Closed -$73.8K – 376
2025
Q3 		$73.8K Buy
+387
New +$68.7K 0.02% 206

Other funds holding DGX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return

JPL Wealth Management's DGX Position: Q1 2026 in Review

JPL Wealth Management opened a new position in Quest Diagnostics (DGX) in Q1 2026: 397 shares worth $77.8K. The stake represents 0.02% of the portfolio and ranks #183 among its holdings. This is a return to the name: JPL Wealth Management previously reported a position in DGX as recently as Q3 2025.

JPL Wealth Management first reported a position in DGX in Q3 2025 and has held it in 2 quarters since. 1,063 funds tracked by Wall St. Rank hold DGX as of Q1 2026.

  • JPL Wealth Management held 397 shares of Quest Diagnostics worth $77.8K as of Q1 2026.
  • Quest Diagnostics was a new JPL Wealth Management position in Q1 2026.
  • Quest Diagnostics made up 0.02% of JPL Wealth Management's portfolio in Q1 2026, its #183 holding.
  • JPL Wealth Management first reported a position in Quest Diagnostics in Q3 2025 and has held it in 2 quarters since.
  • 1,063 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.

Based on JPL Wealth Management's 13F filing for Q1 2026, filed 8 May 2026.